E-cadherin gene mutations are rare in adenocarcinomas of the oesophagus

British Journal of Cancer

Volumn 80, Issue 10, 1999, Pages 1652-1657

  Wijnhoven, B P L ^a   De Both, N J ^b   Van Dekken, H ^b   Tilanus, H W ^a   Dinjens, W N M ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b JOSEPHINE NEFKENS INSTITUTE   (Netherlands)

Author keywords

Adenocarcinoma oesophagus; E cadherin; LOH; Mutations; PCR SSCP

Indexed keywords

UVOMORULIN;

ADENOCARCINOMA; ANIMAL EXPERIMENT; ARTICLE; CHROMOSOME 16Q; ESOPHAGUS CARCINOMA; EXON; GENE DELETION; GENE MUTATION; GENETIC SCREENING; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; STOP CODON;

ADENOCARCINOMA; CADHERINS; ESOPHAGEAL NEOPLASMS; HUMANS; LOSS OF HETEROZYGOSITY; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL;

EID: 0032991168     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690577     Document Type: Article

References (34)

1. Bailey T, Biddlestone L, Shepherd N, Barr H, Warner P and Jankowski J (1998) Altered cadherin and catenin complexes in the Barrett's esophagus-dysplasia-adenocarcinoma sequence: correlation with disease progression and dedifferentiation. Am J Pathol 152: 135-144
2. Becker KF and Hofler H (1995) Frequent somatic allelic inactivation of the E-cadherin gene in gastric carcinomas. J Natl Cancer Inst 87: 1082-1084
3. Becker KF, Atkinson MJ, Reich U, Becker I, Nekarda H, Siewert JR and Hofler H (1994) E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res 54: 3845-3852
4. Berx G, Cleton-Jansen AM, Nollet F, de Leeuw WJ, van de Vijver M, Cornelisse C and van Roy F (1995) E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers. Embo J 14: 6107-6115
5. Berx G, Cleton-Jansen AM, Sltrumane K, de Leeuw WJ, Nollet F, van Roy F and Cornelisse C (1996) E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain. Oncogene 13: 1919-1925
6. Bongiorno PF, al-Kasspooles M, Lee SW, Rachwal WJ, Moore JH, Whyte RI, Orringer MB and Beer DG ( 1995) E-cadherin expression in primary and metastatic thoracic neoplasms and in Barrett's oesophagus. Br J Cancer 71: 166-172
7. de La Coste A, Romagnolo B, Billuart P, Renard CA, Buendia MA, Soubrane O, Fabre M, Chelly J, Beldjord C, Kahn A and Perret C (1998) Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc Natl Acad Sci USA 95: 8847-8851
8. Frixen UH, Behrens J, Sachs M, Eberle G, Voss B, Warda A, Lochner D and Birchmeier W (1991) E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 113: 173-185
9. Gabbert HE, Mueller W, Schneiders A, Meier S, Moll R, Birchmeier W and Hommel G (1996) Prognostic value of E-cadherin expression in 413 gastric carcinomas. Int J Cancer 69: 184-189
10. Gayther SA, Gorringe KL, Ramus SJ, Huntsman D, Roviello F, Grehan N, Machado JC, Pinto E, Seruca R, Halling K, MacLeod P, Powell SM, Jackson CE, Ponder BAJ and Caldas C (1998) Identification of germ-line E cadherin mutations in gastric cancer families of European origin. Cancer Res 58: 4086-4089
11. Graff JR, Groenberg VE, Herman JG, Westra WH, Boghaert ER, Ain KB, Saji M Zeiger MA, Zimmer SG and Baylin SB (1998) Distinct patterns of E cadherin CpG island methylation in papillary, lollicular, Hurthle's cell, and poorly differentiated human thyroid carcinoma. Cancer Res 58: 2063-2066
12. Guilford P, Hopkins J, Harraway J, McLeod M, McLeod N, Harawira P, Taite H, Scoular R, Miller A and Reeve AE (1998) E-cadherin germline mutations in familial gastric cancer. Nature 392: 402-405
13. Hiraguri S, Godfrey T, Nakamura H, Graff J, Collins C, Shayesteh L, Doggett N, Johnson K, Wheelock M, Herman J, Baylin S, Pinkel D and Gray J (1998) Mechanisms of inactivation of E-cadherin in breast cancer cell lines. Cancer Res 58: 1972-1977
14. Hyas M, Tomlinson IP, Hanby A, Talbot IC and Bodmer WF (1997) Allele loss, replication errors and loss of expression of E-cadherin in colorectal cancers. Gut 40: 654-659
15. Iwao K, Nakamori S, Kameyama M, Imaoka S, Kinoshita M, Fukui T, Ishiguro S, Nakamura Y and Miyoshi Y (1998) Activation of the beta-catenin gene by interstitial deletions involving exon 3 in primary colorectal carcinomas without adenomatous polyposis coli mutations. Cancer Res 58: 1021-1026
16. Kawanishi J, Kato J, Sasaki K, Fujii S, Watanabe N and Niitsu Y (1995) Loss of E-cadherin-dependent cell-cell adhesion due to mutation of the beta-catenin gene in a human cancer cell line, HSC-39. Mol Cell Biol 15: 1175-1181
17. Krishnadath KK, Tilanus HW, van Blankenstein M, Hop WC, Kremers ED, Dinjens WN and Bosman FT (1997) Reduced expression of the cadherin catenin complex in oesophageal adenocarcinoma correlates with poor prognosis. J Pathol 182: 331-338
18. Kuczyk M, Serth J, Machtens S, Bokemeyer C, Bathke W, Stief C and Jonas U (1998) Expression of E-cadherin in primary prostate cancer: correlation with clinical features [In Process Citation]. Br J Urol 81: 406-412
19. Oda T, Kanai Y, Oyuma T, Yoshiura K, Shimoyama Y, Birchmeier W, Sugimura T and Hirohashi S (1994) E cadherin gene mutations in human gastric carcinoma cell lines. Proc Natl Acad Sci USA 91: 1858-1862
20. Orita M, Iwahana H, Kanazawa H, Hayashi K and Sekiya T (1989) Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci USA 86: 2766-2770
21. Perl AK, Wilgenbus P, Dahl U, Semb H and Christofori G (1998) A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 392: 190-193
22. Risinger JI, Berehuek A, Kohler MF and Boyd J (1994) Mutations of the E-cadherin gene in human gynecologic cancers. Nat Genet 7: 98-102
23. Rockett JC, Larkin K, Darnton SJ, Morris AG and Matthews HR (1997) Five newly established oesophageal carcinoma cell lines: phenotypic and immunological characterization. Br J Cancer 75: 258-263
24. Saito Y, Takazawa H, Uzawa K, Tanzawa H and Sato K (1998) Reduced expression of E-cadherin in oral squamous cell carcinoma: relationship with DNA methylation of 5′ CpG island. Int J Oncol 12: 293-298
25. Sheffield VC, Beek JS, Kwitck AE, Sandstrom DW and Stone EM (1993) The sensitivity of single-strand conformation polymorphism analysis for the detection of single base substitutions. Genomics 16: 325-332
26. Shimoyama Y, Nagafuchi A, Fujita S, Gotoh M, Takeichi M, Tsukita S and Hirohashi S (1992) Cadherin dysfunction in a human cancer cell line: possible involvement of loss of alpha-catenin expression in reduced cell -cell adhesiveness. Cancer Res 52: 5770-5774
27. Soares P, Berx G, van Roy F and Sobrinho-Simoes M (1997) E-cadherin gene alterations are rare events in thyroid tumors. Int J Cancer 70: 32-38
28. Sulzer MA, Leers MP, van Noord JA, Bollen EC and Theunissen PH (1998) Reduced E-cadherin expression is associated with increased lymph node metastasis and unfavorable prognosis in non-small cell lung cancer. Am J Respir Crit Care Med 157: 1319-1323
29. Swami S, Kunible S and Triadafilopoulos G (1995) E-cadherin expression in gastroesophageal reflux disease, Barrett's esophagus, and esophageal adenocarcinoma: an immunohistochemical and immunoblot study. Am J Gastroenterol 90: 1808-1813
30. Takeichi M (1991) Cadherin cell adhesion receptors as a morphogenetic regulator. Science 251: 1451-1455
31. Tamura S (1997) The E-cadherin-mediated cell cell adhesion system in human cancers. Br J Surg 84: 899-900
32. Trapman J, Sleddens HF, van der Weiden MM, Dinjens WN, Konig JJ, Schroder FH, Faher PW and Bosman FT (1994) Loss of heterozygosity of chromosome 8 microsatellite loci implicates a candidate tumor suppressor gene between the loci D8S87 and D8S133 in human prostate cancer. Cancer Res 54: 6061-6064
33. Vleminckx K, Vakaet L, Jr, Mareel M, Fiers W and van Roy F (1991) Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell 66: 107-119
34. Vos CB, Cleton-Jansen AM, Berx G, de Leeuw WJ, ter Haar NT, van Roy F, Cornelisse CJ, Peterse JL and van de Vijver MJ (1997) E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis. Br J Cancer 76: 1131-1133